Your session is about to expire
← Back to Search
Brain Stimulation
tDCS + SLT for Post-Stroke Aphasia
N/A
Recruiting
Led By Dana Moser, PhD, CCC-SLP
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Single left hemisphere stroke etiology
Adequate hearing and vision to complete the tasks
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after 1st and 2nd treatment phases and at 10 follow up after study completion
Awards & highlights
Study Summary
This trial will test if a brain stimulator can help people with aphasia (word retrieval deficits) improve their language skills.
Who is the study for?
This trial is for individuals aged 18-80 who have had a stroke on the left side of their brain at least 6 months ago, resulting in aphasia. They must speak English natively and have good hearing and vision. People with severe comprehension deficits, other neurological diseases or major mental illnesses, conditions not suitable for MRI or tDCS (like seizures), or pregnant women cannot participate.Check my eligibility
What is being tested?
The study is examining if using Transcranial Direct Current Stimulation (tDCS) alongside Speech-Language Therapy (SLT) can improve language skills better than SLT alone in people with aphasia after a stroke. It also looks at how the brain changes functionally during this process.See study design
What are the potential side effects?
Possible side effects of tDCS may include mild tingling, itching, or discomfort at the stimulation site; headache; fatigue; nausea; and insomnia. These are generally short-lived and considered to be mild.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had a stroke that affected the left side of my brain.
Select...
I can see and hear well enough to do tasks.
Select...
I am between 18 and 80 years old.
Select...
I am a native English speaker.
Select...
I have difficulty speaking or understanding language after a stroke.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after 1st and 2nd treatment phases and at 10 follow up after study completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after 1st and 2nd treatment phases and at 10 follow up after study completion
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in correct naming of nouns on Philadelphia Naming Test.
Secondary outcome measures
Change in correct naming of verbs on Action Naming Test
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active tDCS (with Speech-Language Treatment)Active Control1 Intervention
tDCS Stimulation Dose: 1.5 mA for 20-mins
Group II: Sham tDCS (with Speech-Language Treatment)Placebo Group1 Intervention
No tDCS stimulation
Find a Location
Who is running the clinical trial?
University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,303 Total Patients Enrolled
1 Trials studying Aphasia
40 Patients Enrolled for Aphasia
Dana Moser, PhD, CCC-SLPPrincipal InvestigatorUniversity of Arkansas
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- If you are a woman, you are pregnant.I had a stroke that affected the left side of my brain.I can see and hear well enough to do tasks.You have a history of serious mental health conditions like schizophrenia, drug addiction, or bipolar disorder.It has been over 6 months since my stroke.I am between 18 and 80 years old.I am a native English speaker.I have a history of a brain-related condition or injury.You have severe difficulty understanding spoken language, as determined by a test.You have medical conditions that make it unsafe for you to have an MRI or tDCS, like having implanted electrical devices, feeling very anxious in small spaces, or a history of seizures.I have difficulty speaking or understanding language after a stroke.
Research Study Groups:
This trial has the following groups:- Group 1: Sham tDCS (with Speech-Language Treatment)
- Group 2: Active tDCS (with Speech-Language Treatment)
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who has the eligibility to partake in this research?
"This study is seeking to recruit 50 people who have suffered from aphasia, aged between 18 and 80. In addition to this primary requirement, participants must also fulfil the following criteria: Post-stroke aphasic symptoms; single left hemisphere stroke etiology; 6 months post-stroke minimum; be English native speakers with adequate hearing and vision capabilities for completing tasks."
Answered by AI
Is the enrollment period still open for participants of this trial?
"According to the clinicaltrials.gov page, recruitment for this trial is ongoing; it was first announced on September 3rd 2019 and has been revised as recently as October 4th 2022."
Answered by AI
How many people are contributing to this experiment?
"Affirmative. Information hosted on clinicaltrials.gov verifies that this scientific trial, which was first posted on September 3rd 2019, is actively pursuing subjects. It is aiming to enroll 50 individuals from a single medical centre."
Answered by AI
Is this research trial open to minors?
"In order to be qualified for this clinical trial, candidates must reach the age of majority and not exceed 80 years old."
Answered by AI
Recent research and studies
Popular Categories
Share this study with friends
Copy Link
Messenger